Intellia Therapeutics to Present at October Healthcare Investor Conferences
October 03 2017 - 4:35PM
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing
company focused on the development of potentially curative
therapeutics using CRISPR/Cas9 technology, will present at the
following upcoming healthcare conferences in October:
Tuesday, October 10, 2017Chardan Gene
Therapy ConferenceWho: Tom Barnes, Ph.D., Senior Vice
President, Innovation Sciences & eXtelliaLocation: New York,
New YorkPresentation Time: 2:45 pm EDT
Thursday, October 12, 2017Jefferies
Gene Therapy and Editing SummitWho: Nessan Bermingham,
Ph.D., President, Chief Executive Officer and FounderLocation: New
York, New YorkPresentation Time: 1:40 pm EDT
A live webcast of Intellia’s presentations will be accessible
through the Events and Presentations page of the Investor Relations
section of the company’s website at www.intelliatx.com. To access
the webcasts, please log on to the Intellia website approximately
15 minutes prior to the start time to ensure adequate time for any
software downloads that may be required. A replay of the webcast
will be available on Intellia’s website for 14 days following each
conference.
About Intellia Therapeutics
Intellia Therapeutics is a leading genome editing company
focused on the development of proprietary, potentially curative
therapeutics using the CRISPR/Cas9 system. Intellia believes the
CRISPR/Cas9 technology has the potential to transform medicine by
permanently editing disease-associated genes in the human body with
a single treatment course. Our combination of deep scientific,
technical and clinical development experience, along with our
leading intellectual property portfolio, puts us in a unique
position to unlock broad therapeutic applications of the
CRISPR/Cas9 technology and create a new class of therapeutic
products. Learn more about Intellia Therapeutics and CRISPR/Cas9 at
intelliatx.com; Follow us on Twitter @intelliatweets.
Intellia Contacts:
Media
Contact:
Jennifer Mound
Smoter
Senior Vice President, External Affairs
&
Communications
+1
857-706-1071
jenn.smoter@intelliatx.com
Investor Contact: Lindsey TrickettVice
President, Investor Relations+1
857-285-6211lindsey.trickett@intelliatx.com
Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
From Apr 2023 to Apr 2024